TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1-Reference-Cited by-同舟云学术

TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1

Published:2021-02 Issue: Volume:498 Page:142-151
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Shih Chi-Ting,Shiau Chung-Wai,Chen Yen-Lin,Chen Li-Ju,Chao Tzu-I,Wang Cheng-Yi,Huang Chao-Yuan,Hung Man-Hsin,Chen Kuen-Feng

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. The journey from discoveries in fundamental immunology to cancer immunotherapy;Miller;Canc. Cell,2015

2. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012

4. Cancer prevention and therapy through the modulation of the tumor microenvironment;Casey;Semin. Canc. Biol.,2015

5. Macrophage metabolism shapes angiogenesis in tumors;Mantovani;Cell Metabol.,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A detailed insight into macrophages' role in shaping lung carcinogenesis;Life Sciences;2024-09

2. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies;Frontiers in Pharmacology;2024-07-26

3. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy;Journal of Hematology & Oncology;2024-06-11

4. Targeting tumor-associated macrophages to reverse antitumor drug resistance;Aging;2024-05-23

5. Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin;Biomedicine & Pharmacotherapy;2024-04